Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment

By HospiMedica International staff writers
Posted on 16 Sep 2026

Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U. More...

S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify electrocardiogram findings suggestive of urgent acute coronary syndrome (ACS), including ST‑segment elevation myocardial infarction (STEMI) and STEMI equivalents, and to rapidly alert clinicians. The company reports prior deployment in Europe following CE‑marking.

The system analyzes 12‑lead electrocardiograms to flag patterns consistent with life‑threatening coronary occlusion that warrant urgent cardiologist review. Within the PMcardio platform, Queen of Hearts is embedded into existing pre‑hospital, emergency department, and cardiology workflows to support early identification, cardiology consultation, and early cardiac catheterization. The platform is positioned as a care‑coordination layer that carries algorithmic assessment from first medical contact through specialty handoff.

Regulatory clearance via the De Novo pathway establishes a new device classification for AI electrocardiography models that address acute, life‑threatening cardiovascular diagnoses. The authorization follows Breakthrough Device Designation in March 2025 and participation in the Food and Drug Administration’s Total Product Life Cycle Advisory Program. The company indicates it is accelerating U.S. deployment within health systems.

According to the announcement, Queen of Hearts is supported by more than 20 peer‑reviewed studies, including randomized controlled trials across over 40,000 patients on four continents. Published data cited by the company show approximately twofold higher sensitivity than standard of care, up to fivefold fewer false positives, and faster time to treatment. The firm also reports that European use detected more than 120,000 heart attacks in 2025, with reduced treatment times in over half of these cases.

“This milestone reflects our mission to ensure every patient has access to fast, accurate heart attack diagnosis, regardless of where they present. With FDA De Novo authorization in place, we can scale adoption and bring this technology into routine clinical care across the United States,” said Martin Herman, CEO and Co‑founder of Powerful Medical.

Related Links
Powerful Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.